Clinical Trial Update: The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ATLAS Therapy and its effect on nitric oxide bioavailability in patients with intermittent claudication due to peripheral arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• ATLAS Therapy

Snippet

Sponsor: Louis Messina | Conditions: Claudication, Intermittent, Peripheral Artery Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING